Report cover image

Global Animal Antibiotics and Antimicrobials Market Size Study, by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food Producing, Companion) and Region

Publisher Factview Research
Published Jun 27, 2025
Length 285 Pages
SKU # FAVR20179513

Description

The global Animal Antibiotics and Antimicrobials market is currently valued at approximately USD 5.3 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.00% during the forecast period from 2024 to 2034. The market has witnessed a remarkable evolution, driven by the increasing focus on safeguarding animal health, which directly impacts food security and human health. With the rising prevalence of zoonotic diseases and the growing demand for high-quality protein sources, antibiotics and antimicrobials have become essential tools in both therapeutic and preventive veterinary care.

The proliferation of food-producing animals has significantly amplified the demand for antibiotics and antimicrobials, with tetracycline and penicillin accounting for substantial market shares due to their broad-spectrum efficacy. Meanwhile, advanced delivery methods such as oral solutions and premixes are revolutionizing treatment accessibility, particularly in large-scale farming operations. Furthermore, the surge in pet ownership has catalyzed the demand for companion animal therapeutics, thereby diversifying the market’s application spectrum.

Despite its promising growth, the market grapples with challenges such as stringent regulations on antimicrobial usage to curb resistance and a shift toward alternatives in line with global health initiatives. However, innovations in antimicrobial formulations and strategic alliances to expand market reach are poised to mitigate these challenges. The emergence of sustainable practices and precision medicine in animal health offers a promising horizon for market stakeholders.

Regionally, North America dominates the animal antibiotics and antimicrobials market, attributed to its advanced veterinary infrastructure and strong regulatory oversight ensuring the judicious use of antimicrobials. Europe follows closely, benefiting from stringent policies that promote sustainable animal farming practices. In contrast, the Asia-Pacific region is expected to witness the fastest growth, driven by increasing livestock populations, burgeoning meat consumption, and government initiatives aimed at improving veterinary healthcare infrastructure in emerging economies such as India and China.

Major market players included in this report are:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck Animal Health
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • Virbac
  • Phibro Animal Health Corporation
  • Vetoquinol
  • Bayer Animal Health
  • Dechra Pharmaceuticals PLC
  • Zydus Animal Health
  • Huvepharma
  • Norbrook Laboratories Limited
  • Neogen Corporation
  • HIPRA
The detailed segments and sub-segment of the market are explained below:

By Product
  • Tetracycline
  • Penicillin
  • Sulfonamide
  • Macrolide
  • Cephalosporin
  • Lincosamide
By Mode of Delivery
  • Premixes
  • Oral Solution
  • Injection
By Animal
  • Food Producing
  • Companion
By Region:

North America
  • U.S.
  • Canada
Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
Latin America
  • Brazil
  • Mexico
Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
Years considered for the study are as follows:
  • Historical year – 2022
  • Base year – 2024
  • Forecast period – 2024 to 2034
Key Takeaways:
  • Market estimates and forecasts spanning a decade from 2022 to 2032.
  • Regional insights, with country-level analyses for major markets.
  • Competitive landscape profiling key market players and their strategic initiatives.
  • Actionable recommendations tailored for market participants.

Table of Contents

285 Pages
Chapter 1. Global Animal Antibiotics and Antimicrobials Market Executive Summary
1.1. Global Animal Antibiotics and Antimicrobials Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.1.1. Tetracycline
1.3.1.2. Penicillin
1.3.1.3. Sulfonamide
1.3.1.4. Macrolide
1.3.1.5. Cephalosporin
1.3.1.6. Lincosamide
1.3.2. By Mode of Delivery
1.3.2.1. Premixes
1.3.2.2. Oral Solution
1.3.2.3. Injection
1.3.3. By Animal
1.3.3.1. Food Producing
1.3.3.2. Companion
1.4. Key Trends
1.5. Recession Impact
1.6. Investment Analysis
1.7. Investment Rationale
1.8. Analyst Recommendation & Conclusion
Chapter 2. Global Animal Antibiotics and Antimicrobials Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Animal Antibiotics and Antimicrobials Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Focus on Animal Health and Food Security
3.1.2. Rising Prevalence of Zoonotic Diseases
3.1.3. Growing Demand for High-Quality Protein Sources
3.2. Market Challenges
3.2.1. Stringent Regulations on Antimicrobial Usage
3.2.2. Emergence of Antimicrobial Resistance
3.3. Market Opportunities
3.3.1. Innovations in Antimicrobial Formulations
3.3.2. Strategic Alliances to Expand Market Reach
3.3.3. Adoption of Sustainable and Precision Medicine Practices
Chapter 4. Global Animal Antibiotics and Antimicrobials Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Animal Antibiotics and Antimicrobials Market Size & Forecasts by Product 2024-2034
5.1. Segment Dashboard
5.2. Global Animal Antibiotics and Antimicrobials Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Tetracycline
5.2.2. Penicillin
5.2.3. Sulfonamide
5.2.4. Macrolide
5.2.5. Cephalosporin
5.2.6. Lincosamide
Chapter 6. Global Animal Antibiotics and Antimicrobials Market Size & Forecasts by Mode of Delivery 2024-2034
6.1. Segment Dashboard
6.2. Global Animal Antibiotics and Antimicrobials Market: Mode of Delivery Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Premixes
6.2.2. Oral Solution
6.2.3. Injection
Chapter 7. Global Animal Antibiotics and Antimicrobials Market Size & Forecasts by Animal 2024-2034
7.1. Segment Dashboard
7.2. Global Animal Antibiotics and Antimicrobials Market: Animal Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. Food Producing
7.2.2. Companion
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Zoetis Inc.
8.1.2. Elanco Animal Health Incorporated
8.1.3. Merck Animal Health
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Zoetis Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Elanco Animal Health Incorporated
8.3.3. Merck Animal Health
8.3.4. Boehringer Ingelheim
8.3.5. Ceva Santé Animale
8.3.6. Virbac
8.3.7. Phibro Animal Health Corporation
8.3.8. Vetoquinol
8.3.9. Bayer Animal Health
8.3.10. Dechra Pharmaceuticals PLC
8.3.11. Zydus Animal Health
8.3.12. Huvepharma
8.3.13. Norbrook Laboratories Limited
8.3.14. Neogen Corporation
8.3.15. HIPRA
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us